Current Drug Targets | BenthamScience

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Related Journals

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

Related E-Books

Bentham ebook::Frontiers in Drug Design and Discovery

Bentham ebook::In Silico and In vitro Approaches to Screen the Anti-TB Activity of Benzothiazole Analogs

Bentham ebook::Anti-Obesity Drug Discovery and Development

Bentham ebook::Anti-Angiogenesis Drug Discovery and Development

Bentham ebook::Bioactive Phytochemicals: Drug Discovery to Product Development

Bentham ebook::Frontiers in Anti-Cancer Drug Discovery

Bentham ebook::Frontiers in Cardiovascular Drug Discovery

Bentham ebook::Frontiers in Anti-Infective Drug Discovery

Bentham ebook::Frontiers in CNS Drug Discovery

Bentham ebook::Drug Design and Discovery in Alzheimer’s Disease

Bentham ebook::Erythropoietic Stimulating Agents

Bentham ebook::The 1 International Conference on Drug Design and Discovery February 4 - 7, 2008, Dubai, UAE

Bentham ebook::The Search for Antidepressants - An Integrative View of Drug Discovery

Bentham ebook::Translational Animal Models in Drug Discovery and Development

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More